UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the ~~Month~~month of January 2026

Commission file number 001-41291

Meihua International Medical Technologies Co., Ltd.

(Translation of registrant’s name into English)

88 Tongda Road, Touqiao Town

Guangling District, Yangzhou, 225000

People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒  Form 40-F  ☐

~~Change~~Investors’ ofEntry ~~Auditor~~into the Lock-up Agreement

OnAs ~~December~~previously 26disclosed, ~~2025,~~ Meihua International ~~Medical~~ Medical Technologies Co., Ltd. (the “Company”), ~~upon~~entered ~~the~~into ~~approval~~a ofsecurities ~~the~~purchase ~~board~~agreement ofwith ~~directors~~several of“non-U.S. ~~the Company~~ Persons” (the “~~Board~~October Purchasers”) ~~and~~ ~~the~~as ~~audit~~defined ~~committee~~in Regulation S of the ~~Board~~Securities Act of 1933, as amended (“the ~~“Audit~~Securities ~~Committee~~Act”), on ~~dismissed~~October ~~Kreit~~8, &2025 ~~Chiu~~for ~~CPA~~a ~~LLP~~private ~~(“Kreit~~placement &of ~~Chiu CPA”)~~40,000,000 ~~the~~ordinary ~~former~~shares ~~independent~~of ~~registered~~the ~~public~~Company, ~~accounting~~par ~~firm~~value of ~~the~~$0.0005 ~~Company~~per ~~and~~share, ~~appointed~~or Li400,000 ~~CPA~~Class A ~~LLC~~ordinary ~~(PCAOB~~Shares, ~~ID:~~par ~~7093)~~value $0.05 per share on a post reverse-split and post re-designation basis (the “~~Li CPA~~Class A Ordinary Shares”), for togross ~~serve~~proceeds asof ~~its~~$15.2 ~~independent~~million ~~registered~~(the ~~public~~“October ~~accounting~~Offering”). ~~firm~~The ~~for~~October ~~the~~Offering ~~year~~fully ~~ended~~closed ~~December~~on 31January 20, ~~2025~~2026.

~~Kreit~~As &previously ~~Chiu~~disclosed, ~~CPA’s reports~~ on ~~the Company’s financial statements for the fiscal year ended~~ December 315, ~~2024~~2025, the ~~2023,~~Company ~~and~~entered ~~2022~~into ~~did not contain an adverse opinion or~~ a ~~disclaimer~~securities ~~of opinion~~purchase ~~and~~agreement ~~were~~with ~~not~~certain ~~qualified or modified as to uncertainty, audit scope, or accounting principles~~“non-U.S. ~~Furthermore,~~Persons” ~~during~~ (the ~~Company’s two most recent fiscal years ended~~ “December ~~31,~~Purchasers”) as ~~2024,~~defined ~~there~~in ~~were~~Regulation noS ~~disagreements with Kreit & Chiu CPA on any matter~~ of ~~accounting principles~~the orSecurities ~~practices~~Act, ~~financial~~offering ~~statement~~up ~~disclosure, or auditing scope or procedure, which disagreements, if not resolved~~ to ~~the~~an ~~satisfaction~~ aggregate of ~~Kreit & Chiu CPA~~120,000 ~~would~~Class ~~have~~A ~~caused~~Ordinary ~~Kreit~~Shares ~~& Chiu CPA to make reference to the subject matter~~ of the ~~disagreements in connection with its reports on the~~ Company’s, ~~financial statements~~ for ~~such~~gross proceeds ~~year.~~of ~~Also~~$1, ~~during this time~~320,000 ~~there~~(the ~~were no~~ “~~reportable~~December ~~events,~~Offering” as). ~~defined~~The inDecember ~~Item~~Offering ~~304(a)(1)(v)~~closed ofon ~~Regulation~~December ~~S-K~~15, 2025.

~~The~~On ~~Company~~January ~~provided~~22, ~~Kreit~~2026, &each ~~Chiu~~of ~~CPA~~the ~~with~~October Purchasers aand ~~copy of~~ the ~~above~~December ~~disclosure~~Purchasers ~~and~~(collectively, ~~requested~~the ~~that~~“Purchasers”) ~~Kreit~~entered &into ~~Chiu~~a ~~CPA~~lock-up ~~furnish~~agreement (the ~~Company~~“Lock-Up Agreement”) with athe ~~letter~~Company, ~~addressed~~pursuant to which the ~~U.S.~~Purchasers ~~Securities~~agreed that, from the date of the Lock-Up Agreement until twelve (12) months following the closing of the October Offering and ~~Exchange~~the ~~Commission~~December ~~stating~~Offering, ~~whether~~the orPurchasers will not, itwithout ~~agrees~~the ~~with~~prior written consent of the ~~above~~Company, offer, ~~statements.~~sell, Acontract ~~copy~~to sell, hypothecate, pledge, or otherwise dispose of any securities of the ~~Kreit~~Company &beneficially ~~Chiu~~owned, ~~CPA’s~~held, ~~letter~~or isthereafter acquired by the Purchaser (the “Securities”), or make any demand for, exercise any right to require, or cause to be filed asany ~~Exhibit~~registration ~~16.1~~statement (or any amendment thereto) with respect to ~~this~~the ~~Form~~registration ~~6-K~~of the Securities.

~~During~~A ~~the~~form ~~two most recent fiscal years and any subsequent interim periods prior to the engagement~~ of ~~Li CPA, neither~~ the ~~Company,~~Lock-Up ~~nor~~Agreement ~~someone~~is onfurnished ~~behalf of the Company, has consulted~~hereto Lias ~~CPA~~Exhibit ~~regarding~~99.1 ~~(i)~~and ~~the~~such ~~application~~document ofis ~~accounting~~incorporated ~~principles~~herein toby ~~any~~reference. ~~specified~~The ~~transaction,~~foregoing ~~either~~is ~~completed~~only ora ~~proposed~~brief ordescription ~~the type~~ of ~~audit~~ ~~opinion that might be rendered on~~ the ~~Company’s~~material ~~consolidated financial statements, and neither a written report nor oral advice~~terms ~~was~~of ~~provided to~~ the ~~Company~~Lock-Up ~~that~~Agreement Liand ~~CPA~~does ~~concluded~~not ~~was~~purport ~~an important factor considered by the Company in reaching a decision as~~ to ~~any~~be ~~accounting, auditing, or financial reporting issue, or (ii) any matter that was either the subject of~~ a ~~“disagreement,”~~complete asdescription ~~defined in Item 304(a)(1)(iv)~~ of ~~Regulation~~the ~~S-K,~~rights orand aobligations ~~“reportable event,” as defined in Item 304(a)(1)(v)~~ of ~~Regulation~~the ~~S-K,~~parties orthereunder ~~any other~~and ~~matters~~is ~~set~~qualified ~~forth~~ in ~~Item~~its ~~304(a)(2)(i)~~entirety ~~and~~by ~~(ii)~~reference ofto ~~Regulation~~such ~~S-K~~ exhibit.

~~Financial Statements and~~ Exhibits.

Exhibit No.		Description
16.1		Letter from Kreit & Chiu CPA to the U.S. Securities and Exchange Commission dated January 7, 2026
99.1		Form of the Lock-Up Agreement

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Meihua International Medical Technologies Co., Ltd.
By:	/s/ Leyi Lee
Name:	Leyi Lee
Title:	Chief Executive Officer
Date: January 7, 2026
Date: January 22, 2026

Filing Compare · Meihua International Medical Technologies Co., Ltd.